Heartseed, Inc.
Status: Publicly traded
Last reviewed: October 2026
Direct answer
Heartseed, Inc. is publicly traded on JPX under the ticker 219A.T.
Heartseed Inc. is a Japan-based company engaged in research and development of regenerative medicine products. The company has established cardiac regenerative medicine, a therapy in which microtissue derived from iPS cells is transplanted into the heart for patients with severe heart failure. Target diseases include dilated cardiomyopathy, old myocardial infarction, and dilated-phase hypertrophic cardiomyopathy.
Can you invest in Heartseed, Inc.?
Yes. Heartseed, Inc. is publicly traded on JPX under the ticker 219A.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Heartseed, Inc.
Detailed equity research is provided by MarketSnap.